← Back to all articles
Industry Insights

Overcoming Challenges in Stereoselective Synthesis

By Analytical R&D Unit
Overcoming Challenges in Stereoselective Synthesis

The Importance of Chiral Purity

Many modern APIs exist as enantiomers, where only one structural variation possesses the desired therapeutic effect. The wrong enantiomer can be inactive or worseβ€”have adverse side effects. Producing these requires rigorous stereoselective synthesis and subsequent chiral separation.

Implementing Advanced Techniques

At our R&D laboratories, we deploy state-of-the-art crystallization and chromatography techniques to isolate the desired isomers. Molecules like Lacosamide demand exceptional precision, and our analytical capabilities ensure our yields hit up to 99.9% enantiomeric excess (ee).

Partnering with PEC Pharma for CDMO ensures your molecule avoids late-stage developmental roadblocks caused by stereochemical impurities.


Interested in discussing this further?

Our team is available for technical discussions and CDMO partnership queries.

Contact Us Today